Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
4
currently held
Exits tracked
5
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin9 companies matching
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
Ivantis Mérieux Innovation 1 | Merieux Equity Partners | 2017 | 5yr | Exited 2022 | Alcon | – | |||
CVRx Ysios BioFund II Innvierte | Ysios Capital Partners | 2013 | 8yr | Exited 2021 | – | – | |||
Avedro Abingworth Bioventures VI | Abingworth | 2014 | 5yr | Exited 2019 | Glaukos | – | |||
Kalila Medical Mérieux Innovation 1 | Merieux Equity Partners | 2014 | 2yr | Exited 2016 | Abbott Laboratories | – | |||
Medtech Newfund I | Newfund Management | 2010 | 3yr | Exited 2013 | Zimmer Biomet | – | |||
Capsa Healthcare Direct investment by Peugeot Invest | Peugeot Invest | 2017 | 9yr | Active | – | – | |||
Laborie Patricia Industries | Patricia Industries | 2016 | 10yr | Active | – | – | |||
Nova Biomedical Patricia Industries | Patricia Industries | 2020 | 6yr | Active | – | – | |||
Rivermark Medical BioDiscovery 7 | Andera Partners | 2026 | 0yr | Active | – | – |
Ivantis
Mérieux Innovation 1
USSector
MedTech
InvestorMerieux Equity Partners
Entry
2017
Hold
5yr
Exit
2022
to Alcon
CVRx
Ysios BioFund II Innvierte
USSector
MedTech
InvestorYsios Capital Partners
Entry
2013
Hold
8yr
Exit
2021
Avedro
Abingworth Bioventures VI
USSector
MedTech
InvestorAbingworth
Entry
2014
Hold
5yr
Exit
2019
to Glaukos
Kalila Medical
Mérieux Innovation 1
USSector
MedTech
InvestorMerieux Equity Partners
Entry
2014
Hold
2yr
Exit
2016
to Abbott Laboratories
Medtech
Newfund I
USSector
MedTech
InvestorNewfund Management
Entry
2010
Hold
3yr
Exit
2013
to Zimmer Biomet
Capsa Healthcare
Direct investment by Peugeot Invest
USSector
MedTech
InvestorPeugeot Invest
Entry
2017
Hold
9yr
Laborie
Patricia Industries
USSector
MedTech
InvestorPatricia Industries
Entry
2016
Hold
10yr
Nova Biomedical
Patricia Industries
USSector
MedTech
InvestorPatricia Industries
Entry
2020
Hold
6yr
Rivermark Medical
BioDiscovery 7
USSector
MedTech
InvestorAndera Partners
Entry
2026
Hold
0yr